Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphomaResearch in context

Background: Treatment for Cutaneous T Cell Lymphoma (CTCL) is generally not curative. Therefore, selecting therapy that is effective and tolerable is critical to clinical decision-making. Histone deacetylase inhibitors (HDACi), epigenetic modifier drugs, are commonly used but effective in only ~30%...

Full description

Bibliographic Details

Published in:	EBioMedicine
Main Authors:	Jared M. Andrews, Jennifer A. Schmidt, Kenneth R. Carson, Amy C. Musiek, Neha Mehta-Shah, Jacqueline E. Payton
Format:	Article
Language:	English
Published:	Elsevier 2019-08-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396419304955